Howe & Rusling Inc Revance Therapeutics, Inc. Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$12.46 - $27.87 $560 - $1,254	-45 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.78 - $33.21 $335 - $431	13 Added 40.63%	45 $1,000
Q1 2021 May 13, 2021	SELL	$24.03 - $29.97 $120 - $149	-5 Reduced 13.51%	32 $1,000
Q4 2020 Feb 08, 2021	BUY	$23.41 - $28.34 $866 - $1,048	37 New	37 $1,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.